The estimated Net Worth of Fred Telling is at least $673 mil dollars as of 30 November 2023. Dr Telling owns over 3,500 units of Oragenics Inc stock worth over $19,173 and over the last 18 years he sold OGEN stock worth over $545,872. In addition, he makes $107,500 as Exec. Chairman at Oragenics Inc.
Sign up
Dr D OGEN stock SEC Form 4 insiders trading
Dr has made over 13 trades of the Oragenics Inc stock since 2010, according to the Form 4 filled with the SEC. Most recently he sold 3,500 units of OGEN stock worth $12,495 on 30 November 2023.
The largest trade he's ever made was selling 216,016 units of Oragenics Inc stock on 5 November 2010 worth over $84,246. On average, Dr trades about 17,121 units every 75 days since 2006. As of 30 November 2023 he still owns at least 38,345 units of Oragenics Inc stock.
You can see the complete history of Dr Telling stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Dr. Frederick W. Telling Ph.D. biography
Dr. Frederick W. Telling Ph.D. is the Exec. Chairman at Oragenics Inc.
What is the salary of Dr D?
As the Exec. Chairman of Oragenics Inc, the total compensation of Dr D at Oragenics Inc is $107,500. There are 3 executives at Oragenics Inc getting paid more, with Michael O. Sullivan CPA having the highest compensation of $297,210.
How old is Dr D?
Dr D is 69, he's been the Exec. Chairman of Oragenics Inc since . There are no older and 8 younger executives at Oragenics Inc.
What's Dr D's mailing address?
Fred's mailing address filed with the SEC is 4902 EISENHOWER BOULEVARD, , TAMPA, FL, 33634.
Insiders trading at Oragenics Inc
Over the last 12 years, insiders at Oragenics Inc have traded over $5,827,684 worth of Oragenics Inc stock and bought 8,095,027 units worth $13,189,855 . The most active insiders traders include Randal Jintrexon Corp Kirk, Joseph Hernandez, eRobert C Koski. On average, Oragenics Inc executives and independent directors trade stock every 60 days with the average trade being worth of $151,398. The most recent stock trade was executed by Fred Telling on 30 November 2023, trading 3,500 units of OGEN stock currently worth $12,495.
What does Oragenics Inc do?
oragenics is a publicly-traded biopharmaceutical company with a pipeline of unique proprietary technologies. offerings are based on the probiora3 technology and brands include evoraplus™ is a new, one-of-a-kind probiotic mint that naturally supports gum and tooth health while freshening breath and whitening teeth. oragenics has a number of products in discovery, preclinical and clinical development, with a concentration in the main therapeutic area of infectious diseases, in diagnostics, and in oral health.
What does Oragenics Inc's logo look like?
Complete history of Dr Telling stock trades at CTI BioPharma Corp e Oragenics Inc
Oragenics Inc executives and stock owners
Oragenics Inc executives and other stock owners filed with the SEC include:
-
Michael O. Sullivan CPA,
CFO, Sec., Treasurer & Interim Principal Exec. Officer -
Dr. Martin Handfield M.Sc., Ph.D.,
Sr. VP of Discovery Research -
Michael Sullivan,
Chief Financial Officer, Treasurer, Secretary -
Dr. Frederick W. Telling Ph.D.,
Exec. Chairman -
Charles Pope,
Independent Director -
Robert Koski,
Independent Director -
Alan Dunton,
Independent Director -
Kim Murphy,
Director -
Alan Joslyn,
President, Chief Executive Officer, Director -
Frederick Telling,
Independent Chairman of the Board -
Dr. Raman Bedi,
Chairman of International Scientific Advisory Board and Sr. Consultant -
Joseph Hernandez,
10% owner -
John P Gandolfo,
Director -
Bruce A. Sr. Cassidy,
Director -
Randal Jintrexon Corp Kirk,
-
Fred Telling,
Director -
Family Lpkoski Robert Ckosk...,
-
Janet Huffman,
CFO, Secretary and Treasurer -
Christine L Koski,
-
Family Lp Koski,
-
Thomas L Koski,
-
Beverly Koski,
-
Robert Ckoski Christine Lko...,
-
Family Lpkoski Christine Lk...,
-
John N Bonfiglio,
President and CEO -
Family Lpkoski Beverlykoski...,
-
J Michael Redmond,
President -
Robert C Koski,
Director